Your browser doesn't support javascript.
loading
Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.
Fabbri, Alice; Swandari, Swestika; Lau, Edith; Vitry, Agnes; Mintzes, Barbara.
Afiliación
  • Fabbri A; 1 Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Swandari S; 2 Makassar Health Training Centre, Ministry of Health, Makassar, Indonesia.
  • Lau E; 1 Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
  • Vitry A; 3 School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia.
  • Mintzes B; 1 Charles Perkins Centre and School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Int J Health Serv ; 49(2): 273-293, 2019 04.
Article en En | MEDLINE | ID: mdl-30646806
Relationships between consumer organizations and pharmaceutical manufacturers are the focus of transparency efforts in some jurisdictions, including Australia. This study describes the frequency and nature of industry sponsorship of Australian health consumer organizations and examines the link between sponsorship of the most highly funded organizations and manufacturers' requests for public reimbursement of products for related health conditions. We downloaded 130 transparency reports covering the period January 2013 to December 2016 from the website of Medicines Australia and carried out a descriptive analysis. For the most heavily funded organizations and their sponsors, we examined Public Summary Documents of the Pharmaceutical Benefits Advisory Committee to identify relevant products under consideration for public reimbursement over the study period. Thirty-four pharmaceutical companies provided 1,482 sponsorships to 230 organizations, spending a total of AU$34,507,810. The top clinical areas in terms of amount of funding received were cancer, eye health, and nervous system disorders. The sponsors of the most highly funded groups were companies that in most cases had drugs under review for public reimbursement for conditions covered by these organizations. Interactions between the pharmaceutical industry and consumer organizations are common and require careful management to prevent biases that may favor sponsors' interests above those of patients and the public.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Defensa del Consumidor / Industria Farmacéutica / Financiación de la Atención de la Salud Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Int J Health Serv Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Defensa del Consumidor / Industria Farmacéutica / Financiación de la Atención de la Salud Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Oceania Idioma: En Revista: Int J Health Serv Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos